dr. J.W.C. (Jan-Willem) Alffenaar

hospital pharmacist - clinical pharmacologist

dr. J.W.C. (Jan-Willem) Alffenaar
Telephone:
E-mail:
j.w.c.alffenaar umcg.nl

Research

  1. 2020
  2. 2019
  3. Borisov, S., Danila, E., Maryandyshev, A., Dalcolmo, M., Miliauskas, S., Kuksa, L., ... Migliori, G. B. (2019). Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report. European Respiratory Journal, 54(6), [1901522]. https://doi.org/10.1183/13993003.01522-2019
  4. Zuur, M. A., Veenhof, H., Aleksa, A., Boveneind-Vrubleuskaya, N. V. ., Darmawan, E., Hasnain, M. G., ... Alffenaar, J-W. C. (2019). Quality Assessment of Dried Blood Spots from Tuberculosis Patients from Four Countries. Therapeutic Drug Monitoring, 41(6), 714-718. https://doi.org/10.1097/FTD.0000000000000659
  5. Saktiawati, A. M. I., Harkema, M., Setyawan, A., Subronto, Y. W., Sumardi, N. V., Stienstra, Y., ... Sturkenboom, M. G. G. (2019). Optimal Sampling Strategies for Therapeutic Drug Monitoring of First-Line Tuberculosis Drugs in Patients with Tuberculosis. Clinical Pharmacokinetics, 58(11), 1445-1454. https://doi.org/10.1007/s40262-019-00763-3
  6. Global TB Network Clinical Trials, Pontali, E., Raviglione, M. C., & Migliori, G. B. (2019). Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives. European Respiratory Review, 28(152), [190035]. https://doi.org/10.1183/16000617.0035-2019
Previous 1 2 3 4 5 Next

ID: 200721